semaglutide cardiovascular outcomes news 2025 october #VisualAbstract: and in Obesity without Diabetes Semaglutide and Cardiovascular Outcomes in

A., Souza, C

Mental or Physical Fatigue Weekly injections and constant weight management can become emotionally exhausting

N Engl J Med 377(18):17651776

In the UK, recreational cannabis remains a controlled Class B drug under the Misuse of Drugs Act 1971, though medical cannabis can be prescribed in limited circumstances

Alternatives Although retatrutide is the new frontier in obesity management, there are still many effective, FDA-approved pharmaceutical options available to patients today, as well as important lifestyle foundations

Patients can still get coverage if they have a diagnosis of Type 2 diabetes, cardiovascular disease or sleep apnea, but not if they have obesity only or for weight loss generally